Life Sciences Archivi - Pagina 7 di 16

6 novembre 2023

Automated Dispensing Machines – Industry Development and Future Scope

The automated dispensing machines market is growing due to the increasing cases of medication errors, booming geriatric population, technological improvements in such systems, rising incidence of chronic ailments, surging number of patent approvals, and government initiatives to have such equipment in medical settings. Resultingly, the market value in 2020 was $1,673.0 million, and it will be $3,941.9 million in 2030. This revenue increase will likely be at a CAGR of 9.1% between 2021 and 2030.

The application segment of the automated dispensing machines market is bifurcated into in-patient and out-patient, of which the in-patient bifurcation was the larger during the historical period (2015–2020). This is attributed to the surging prevalence of chronic diseases and other issues, such as severe accidents and burns, which usually require people to be admitted to the hospital. Hence, due to the increasing cases of hospitalization, the installation of such systems in in-patient settings is rising fast.

Pharmacies and hospitals are the bifurcations of the market on the basis of end user. Of these, hospitals held the larger share in 2020 as these places are witnessing an increasing footfall. As hospitals employ trained professionals and boast cutting-edge medical equipment and systems, patients trust them the most for disease treatment and consultation. With governments taking initiatives to increase the access to quality healthcare, they are constructing more hospitals every year, which will keep driving the growth of this category during the forecast period.

One of the major reasons for the advance of the automated dispensing machines market is the increasing prevalence of medical error. Taking the wrong drug, or even the right one at the wrong time and wrong dosage, can lead to severe complications. In the U.S., over 100,000 cases of suspected medication errors are reported to the Food and Drug Administration (FDA) each year, which has strengthened the focus on medication management and patient compliance. Automated dispensing machines help in this regard by eliminating the role of humans in distributing medicines to doctors and patients.

The rising demand for medical drugs is itself due to the escalating prevalence of all types of chronic and acute diseases and physical trauma due to injuries, violence, and burns. Moreover, the geriatric population, which is set to number 1.5 billion in 2050 compared to 727 million in 2020, as per the United Nations (UN), is driving the requirement for drugs. This is because the elderly are more susceptible to diseases and at a higher risk of physical injuries.

Similarly, the increasing burden of chronic diseases is driving the automated dispensing machines market advance. Ailments such as cancer, cardiovascular diseases, chronic bronchitis, asthma, and diabetes are lifelong issues, which require non-stop medication for their management. For instance, diabetes patients need to administer insulin almost daily, while asthma patients must have a corticosteroid inhaler ready, to ward off an attack. Further, psychiatric disorders also require a long course of drugs, such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake Iihibitors (SNRIs).

North America dominated the automated dispensing machines market in 2020 because of the increasing technological advancements in these systems, rising geriatric population, and surging burden of chronic diseases. Moreover, the region is home to the largest medical device sector in the world, which leads to an easy availability of advanced automated dispensing machines. Additionally, the heavy spending by state governments in the U.S. on healthcare makes these machines affordable for medical settings.

Therefore, with the strong focus on mitigating medication errors, the market will keep advancing in the coming years.

2 novembre 2023

3D Bioprinting – Industry Development and Forecast Report 2030

The 3D bioprinting market will power at a rate of 19.4% in the future, to reach USD 5,873 million by 2030. Living organs can be printed in 3D by layering living cells, which is the reason why bio engineering is progressively significant to human society.

With the growing requirement for bio-engineered organs, investigators have made key progressions in this tech.

Hence, the expansion of 3D biomaterials and bioprinters, their use in the pharma and cosmetics industries, and the surge in private and public financing for bioprinting research actions are persuading the industry positively.

Doctors make use of additive manufacturing for the creation of new bones and organs, and it is a major innovation in healthcare. Also, this allows the printing of prosthetic limbs for replacing missing limbs.

Additionally, as compared to the traditional process, which needs a long time and a donor, 3D bioprinting allows the transplantation to be done at a much faster pace.

The requirement for indispensable body parts for transplantation is enormously high globally. For making the things worse, there is an enormous gap amid the supply and requirement of tissues and organs. Numerous organs, for example the kidneys, lungs, heart, pancreas, liver, and intestines, are desired for transplantation.

Likewise, the requirement for heart valves, corneas, skin, blood vessels, and bones for transplantation is somewhat high. Rates of organ donation are still, while the requirement for tissues and organs is growing.

The inaccessibility of such parts for transplantation has brought about an increase in count of patients on the transplantation waiting list, a main anxiety for healthcare organization and providers.

Download free sample copy of this report: https://www.psmarketresearch.com/market-analysis/3d-bioprinting-market/report-sample

North America held about 40% share in the recent past, because of the tech-progressions, growing R&D activities and improving healthcare infra. Other than that, the increasing expenditure on healthcare, growing elderly population, and growing prevalence of chronic ailments, is powering the requirement for this tech, particularly in the pharma sector.

APAC 3D bioprinting market will grow the fastest, chiefly due to the fact that its large base of consumers, increasing R&D in this field, and support of the government and tax breaks.

Researchers from China have brought about major progressions in this tech, for instance the liquid-inliquid printing process, in which liquid polymers are combined for forming a steady membrane.

They state that the subsequent liquid developments can hold their shape for about 240 hours, before the combining commences. They printed numerous difficult shapes with the use of this novel method, which has also opened the way for tissue printing from living cells.

The high requirement for tissues and organ transplants all over the world has a lot to do with the increasing demand for 3D bioprinting process.

1 novembre 2023

North America Is Dominating Medical Aesthetics Industry

The medical aesthetics market is projected to be worth USD 34,124.0 million by 2030, growing at a CAGR of 12.4%. This would be a result of the increasing development of technologically enhanced and easy-to-use products and the mounting need for aesthetic treatments among people.

Furthermore, the acceptance of non-invasive and minimally invasive aesthetic methods is increasing worldwide due to the loose facial skin, specifically around the jowls, cheeks, and eyes, and dry skin for others, which are some of the significant changes that typically happen when an individual ages. In addition, the need for aesthetic equipment is growing, because of the surging acceptance of cosmetic methods among common people, to look better.

North America held the largest revenue share in recent years and the continent is also projected to be in the leading position to reach USD 15 billion by 2030. This can be credited to innovation in cosmetic practices as a huge number of future key players and established players either have headquarters or have a significant existence in the region.

Get the sample copy of this report: https://www.psmarketresearch.com/market-analysis/medical-aesthetics-market/report-sample

Moreover, the growing investment in the healthcare sector, the governments’ supportive initiatives for inviting foreign investments, and the mounting R&D development via enhanced technologies are contributing to the growth of the regional market.

The APAC medical aesthetics market is projected to grow at a significant rate in the years to come. Developing countries in the region are showing a significant surge in the use of cosmetic treatments, mainly due to the reasons like increasing per capita income of middle-class people, the aging population, the growing awareness about skin problems, and the snowballing number of medical tourists in the region choosing for cosmetic treatments.

In recent years, the injectables category had the largest revenue share of over 40%, this can be ascribed to growing sales of injectables, including dermal fillers, botulinum toxin, and neurotoxins. In addition, the need for injectables is growing because of several factors like short procedure time, minimal scarring, instant result, cost-efficiency of the products, and minimally invasive.

The beauty clinics category holds the largest revenue share of over 50%, mainly because of the increasing per-capita of many countries, and also the snowballing number of beauty centers throughout the world. Such clinics come with several aesthetic treatments, including wrinkle treatment, body enhancement, augmentation, and scar removal. This is why the demand for dermal fillers and neurotoxins in beauty clinics and centers is increasing.

Hence, the Increasing development of technologically enhanced and easy-to-use products and the mounting need for aesthetic treatments among people are the major factors contributing to the growth of the medical aesthetics market.

30 ottobre 2023

Minimally Invasive Surgical Instruments Demand was Led by North America

As stated in one of its reports by P&S Intelligence, minimally invasive surgical instruments market is projected to touch USD 37,155.7 million by 2030, proceeding at a rate of 7.2% by the end of this decade.

Handheld instruments had the largest share of about 40% in 2022, and the situation will continue to be like this in the years to come.

This has a lot to do with the increasing acceptance of these instruments for a number of MIS surgeries, increasing acceptance of robot-assisted surgeries, and growing preference for such instruments by surgeons.

North America was the leader of the minimally invasive surgical instruments market, with a share of about 40% in 2022, and it will continue like this in the years to come.

This is due to the existence of organized healthcare systems, surge in the occurrence of diseases, for instance orthopedic and cardiac disorders, higher acceptance rate for cutting-edge devices, and shifting preference toward outpatient surgeries.

APAC will grow the fastest, powering at a rate of approximately 10% in the years to come. This is as a result of the growing cases of chronic ailments, rising elderly population, growing consciousness of people with regards to medical device outsourcing, trending medical tourism, and rise in healthcare spending.

The increasing investments in research and development in medical industry is directly proportional to the growing demand for minimally invasive surgical instruments all over the world.

27 ottobre 2023

Intraoperative Neuromonitoring – Industry Development and Future Analysis

The intraoperative neuromonitoring market will increase to USD 4.93 billion by 2030, powering at a rate of 4.8% in the years to come, as stated by a market research institution, P&S Intelligence.

This is credited to the rising incidence of several lifestyle related chronic diseases for example neurological and cardiovascular conditions, the growing emphasis on patient safety throughout complex surgeries, and the increasing requirement for minimally invasive and cutting-edge intraoperative neuromonitoring devices.

Insourced monitoring had a major revenue share, of about 52%, in the past and will maintain its dominance in the years to come. This is as a result of the increased surgical cases, high requirement for consistent monitoring, and augmented attainments by device manufacturers in the years to come to get a direct link with hospitals.

Also, outsourced monitoring is attaining popularity, on account of the reducing costs of healthcare, the plummeting monetary burden of acquiring and sustaining systems, and the mounting count of outsourcing vendors globally.

The elderly population is more susceptible to numerous diseases. The growing life expectancy and dropping birth rate are the key reasons for the growing aging population. With the increase in age, the population will encounter several chronic diseases for example neuropathic disorders, cardiovascular disease, old age-linked trauma, osteoarthritis, and associated orthopedic ailments.

The systems category had a major revenue in the past, and it will grow significantly in the future. This is because of the increasing use of such systems in hospitals and ASCs and the growing necessity to monitor electrophysiological signals from the body of the patient during surgery.

The EMG category dominated the intraoperative neuromonitoring market and it will grow substantially in the future.

This is as a result of its better precision in recognizing possible neurological damage than further monitoring modalities, the increasing requirement for minimally invasive surgeries, the continuing development and growing demand for portable EMG devices to decrease snowballing hospital and healthcare costs, and on the rise healthcare expenditures.

North America led the industry with approximately 51%, in the recent past, and it will maintain its dominance in the years to come. This is credited to the high incidence of neurological ailments, the increased acceptance rate of IONM, existence of sophisticated healthcare infra, the promising reimbursement framework for such innovative neuromonitoring solutions, and the increased patient consciousness pertaining to neurological monitoring.

APAC will grow the fastest in the future. The main reason for this numerous healthcare reforms, the growing requirement for cutting-edge healthcare services in China and India, the increasing prevalence of chronic ailments, and the growing elderly population.

It is because of the increasing research and development activities all over the world, the demand for intraoperative neuromonitoring will continue to rise in the future.

27 ottobre 2023

North America is dominating Capnography Devices Industry

The global capnography devices market is experiencing growth and is projected to reach USD 736.6 million by 2030, according to P&S Intelligence. This growth can be ascribed to the rising occurrence of respiratory illnesses, rising elderly populace, technological improvements in capnography devices, and growing government initiatives, throughout the world.

In the coming few years, the multi-parameter capnography devices category is projected to experience the fastest development in the capnography devices market, based on product type. This can be primarily contributed to the fact that these devices can be combined into patient monitoring systems conveniently for the finding of numerous parameters of patients, and some of them can also be utilized as pulse oximeters.

In recent years, on the basis of technology, Side-stream-based capnography devices had the largest market share in the capnography devices market. This is mainly because of the fact that such devices offer adequate measurable bedside data regarding uneven alveolar emptying and ventilation–perfusion disparity, and this technology needs no standardization before use and has a tremendously short warm-up time enabling its use in emergency circumstances.

Make inquiry before purchase of this report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=capnography-devices-market

In recent years, the North American region dominated the industry, with the largest market share. This can be attributed to the high occurrence of respiratory medical situations, the existence of key industry players providing capnography devices, enhanced healthcare infrastructure, and high knowledge among healthcare professionals, in the continent.

Technological improvements in capnography have been the key boosting reason for the capnography devices industry, which comprise the combination of photo sensors and MCS in micro-stream capnography devices, and the combination of reduced main-stream multi-gas monitors.

Hence, the rising occurrence of respiratory illnesses, the rising elderly populace, technological improvements in capnography devices, and growing government initiatives, are the major factors propelling the capnography devices market.

16 ottobre 2023

Gene Therapy Industry IS Led by North America

The total size of the gene therapy market was USD 7,420 million in 2022, and it will reach USD 29,440 million by 2030, powering at a compound annual growth rate of 18.80% all throughout the projection period, as per a report by P&S Intelligence.

The factors fueling the growth of this industry are the growing R&D investment and increasing approvals of products concerned with gene therapy.

The in-vivo category had the largest share of revenue. This is due to the fact that this method eradicates the need for eliminating the cells from the body of the patients, manipulating them outside the body, and then returning them to their original place.

Furthermore, in vivo gene therapy is beneficial to modify the genetic range of target cells for therapeutic goals. With in-vivo gene therapy, new genetic material is made in a lab and inserted directly into your cells. A vector regularly transmits the new genetic material into the body with the help of an injection in the blood, or directly to the organ, which is targeted.

Pharma and biotech companies were the largest users of this technology. This has a lot to do with the presence of multiple industry players who contracted out the process of vector production to broaden the usage of gene therapy and allow it to treat a lot more illnesses than it now is.

Also, major companies are exploring a variety of strategies of making a market entry, as well as the development of biopharma facilities, partnerships with other substantial companies, and partnerships with contract manufacturing companies.

The increasing occurrence of chronic diseases, including cancer and numerous rare ones, is a key factor in the development of the industry. This is because presently available gene therapies are able to treat numerous rare diseases, particularly those caused because of genetic problems.

For example, as per the figures of the American Cancer Society’s ‘Cancer Facts & Figures 2022’, about 1,918,030 new cancer cases and 609,360 deaths attributable to cancers are reported in the U.S. in 2022.

North America dominated the gene therapy market with about 66%, and it will sustain its dominance in the next few years as well. This is because of the growing occurrence of cancer and the occurrence of numerous leading players.

Furthermore, regulatory authorities are quickly approving gene therapy products, thus fueling the industry expansion. In North America, the U.S. is the larger end-user of gene therapy owing to its cutting-edge healthcare industry and most of the stalwarts have offices here.

APAC will grow the fastest in the future because of the low labor costs and the advent of group investors. Furthermore, regional countries are implementing rules for controlling the procedures for improving gene therapy items.

Due to the increasing prevalence of chronic diseases, the demand for gene therapy will increase substantially in the years to come.

11 ottobre 2023

Home-Use Insulin Delivery Devices Industry Was Dominated by North America

The home-use insulin delivery devices market will generate USD 19,087.6 million in 2030, progressing at a rate of 10.2% in the years to come, as stated by a market research report, published by P&S Intelligence.

The growing pervasiveness of diabetes, tech progressions, increasing aging population, and growing contact of the populace to main risk factors, for example an inactive lifestyle, obesity, and smoking, are main factors powering the industry.

The insulin pens category dominated the industry, on the basis of type. This is mostly credited to the growing incidence of diabetes, particularly in APAC countries, and tech expansions in insulin delivery pens.

Request for sample pages of this report: https://www.psmarketresearch.com/market-analysis/home-use-insulin-delivery-devices-market/report-sample

Moreover, the medical reimbursements provided in advanced nations are augmenting the growth of the market.

Reusable pens dominated the industry in the past, based on the type of insulin pen. This has a lot to do with the user-friendly design of these pens that supports in curtailing the dose errors.

The e-commerce category will grow the fastest in the future, on the basis of distribution channel. This is mostly credited to the development of e-pharmacies offering suitability to the customers. Moreover, the usage of e-prescriptions in hospitals is contributing to the growth of the category globally.

North America dominated the market in the past as a result of the increasing frequency of lifestyle ailments, such as obesity and diabetes, increasing consciousness about diabetes management, and growing healthcare spending.

Furthermore, insulin resistance and obesity have been measured independent risk factors for diabetes; therefore, the increasing obese populace supports the requirement for these devices.

The growing elderly population is a main factor stimulating the development of the home-use insulin delivery devices market. As per a report by the WHO, people are living longer, meaning that the average life expectancy of the populace has increased.

Furthermore, as per the World Population Ageing report in 2020, about 727 million individuals were aged 65 years and more all over the world, and this population will reach 1.5 billion by 2050.

Tech developments in insulin delivery devices are powering their growing acceptance. Insulin pumps, insulin pens and insulin inhalers have numerous compensations, for example precise dosage of insulin, thus helping uphold the usual level of the hormone in the body.

The use of insulin pens is a smaller amount of time consuming as opposed to syringes with vials. Additional advantages of insulin pens comprise superior patient suitability and minimum risk of imprecise dosage.

It is because of the increasing prevalence of diabetes, all over the world, the demand for home-use insulin delivery devices will continue to grow in the years to come.

2 ottobre 2023

Sleep Tech Devices Industry to Observe Fastest Growth in Asia-Pacific

The sleep tech devices market will touch USD 49,984.7 million, propelling at a 14.5% compound annual growth rate, by 2030.

The growth of this industry is primarily attributed to the surging incidence of sleep disorders, growing utilization of oral appliances, and rising consciousness regarding the ill effects of untreated sleep apnea.

In recent years, the wearable category, based on product, accounted for the larger share of the industry. This can be mainly attributed to their portable nature, as well as the enhanced microsensors integrated into the devices that constantly monitor individual physiological activities. Furthermore, wearable devices are more affordable than non-wearable sleep aid devices.

The sleep apnea category, based on application, is likely to propel at the fastest rate in the years to come. This is primarily because of the rising health and stress problems, for instance, excess weight or obesity.

In the past few years, the indirect category, based on distribution channels, accounted for the dominating share of the industry. Most large e-marketplaces are universal platforms, providing goods all over the globe to numerous customers, various businesses are utilizing e-commerce platforms from third parties, which assist in enhancing their revenue from sales in overseas.

North America accounted for the dominating share in recent years. This is because of the increasing chronic sleep disorder incidence, rising count of overweight individuals, mounting aging populace, and fast-moving lifestyle.

The APAC sleep tech devices industry is likely to advance at the fastest rate in the years to come. This is mainly because of the surging advancement in technologies, the increase in the utilization of sleep technology, and the mounting elderly populace.

Moreover, the requirement for sleep technology products is likely to surge due to the fact that the elderly populace has become more inclined to sleep disorders.

It is because of the surging occurrence of sleep disorders, rise in the utilization of oral appliances, and increasing consciousness regarding the dangerous impact of untreated sleep apnea, the sleep tech devices industry will continue to advance significantly in the years to come.

28 settembre 2023

North America Is Dominating Hospital-Acquired Infection Control Industry

The global hospital-acquired infection control market will reach USD 34,909.7 million by 2030 developing at a CAGR of 1.6% during the projection period. This growth can be credited to the growing count of surgical conducts, rising knowledge regarding ecological and personal hygiene, and subsequent development in the occurrence of chronic illnesses.

In the past few years, an extreme surge in occurrences of cardiovascular diseases, neurological syndromes, and traumatic injuries, and the arrival of progressive medical technologies have been experienced. Because of such recurrent events, the industry for hospital-acquired infection control items is surging. For example, annually, the count of individuals going through neurological diseases or accidents is nearly 20 million and approximately 14 million of them need surgery.

The demand for hospital-acquired infection control items in ambulant surgical care centers is projected to advance at the highest CAGR, of 2%, during the forecast period, in the industry.

In recent years, the North American region dominated with the largest share, of 35%, in the hospital-acquired infection control market. This is credited to the rise in the elderly populace, the surge in the occurrence of chronic illnesses and hospital-acquired infections, and the existence of key industry players in the continent.

For example, in the U.S., the count of populaces aged more than 65 years is approximately 45 million and it is projected to reach more than 80 million by 2050. Furthermore, the occurrence of hospital-acquired infections in North America is very prominent. For instance, in American hospitals, the occurrence of HAIs is more than 1.5 million, and annually, 0.1 million demise happens because of this.

Hence, the growing count of surgical conducts, rising knowledge regarding ecological and personal hygiene, and subsequent development in the occurrence of chronic illnesses are the major factors propelling the industry.